Digumarti R - Search Results

1

Lutetium 177 dotatate induced acute myeloid leukemia.

Vallathol DH, Ali AZ, Alapati N, Manasa N, Vasanth P, Digumarti R. Vallathol DH, et al. Among authors: digumarti r. Leuk Lymphoma. 2020 Dec;61(13):3263-3265. doi: 10.1080/10428194.2020.1795158. Epub 2020 Jul 25. Leuk Lymphoma. 2020. PMID: 32713233 No abstract available.

2

Generic Imatinib in Chronic Myeloid Leukemia: Survival of the Cheapest.

Danthala M, Gundeti S, Kuruva SP, Puligundla KC, Adusumilli P, Karnam AP, Bala S, Konatam ML, Maddali LS, Digumarti RR. Danthala M, et al. Clin Lymphoma Myeloma Leuk. 2017 Jul;17(7):457-462. doi: 10.1016/j.clml.2017.05.006. Epub 2017 May 10. Clin Lymphoma Myeloma Leuk. 2017. PMID: 28559151

3

Imatinib mesylate in early chronic phase chronic myeloid leukemia: Experience from a developing country.

Rajappa S, Varadpande L, Paul T, Jacob R, Digumarti R. Rajappa S, et al. Among authors: digumarti r. Leuk Lymphoma. 2008 Mar;49(3):554-8. doi: 10.1080/10428190701824585. Leuk Lymphoma. 2008. PMID: 18297534

4

Kinase domain mutations and responses to dose escalation in chronic myeloid leukemia resistant to standard dose imatinib mesylate.

Rajappa S, Mallavarapu KM, Gundeti S, Roshnipaul T, Jacob RT, Digumarti R. Rajappa S, et al. Among authors: digumarti r. Leuk Lymphoma. 2010 Jan;51(1):79-84. doi: 10.3109/10428190903437629. Leuk Lymphoma. 2010. PMID: 20055659

5

Role of the MDM2 promoter polymorphism (-309T>G) in acute myeloid leukemia development.

Cingeetham A, Vuree S, Jiwatani S, Kagita S, Dunna NR, Meka PB, Gorre M, Annamaneni S, Digumarti R, Sinha S, Satti V. Cingeetham A, et al. Among authors: digumarti r. Asian Pac J Cancer Prev. 2015;16(7):2707-12. doi: 10.7314/apjcp.2015.16.7.2707. Asian Pac J Cancer Prev. 2015. PMID: 25854351 Free article.

6

Chronic myeloid leukemia: An Indian scenario.

Digumarti R. Digumarti R. South Asian J Cancer. 2016 Jul-Sep;5(3):161. doi: 10.4103/2278-330X.187592. South Asian J Cancer. 2016. PMID: 27606305 Free PMC article. No abstract available.

7

Influence of Caspase-9 polymorphisms on the development of Chronic Myeloid Leukemia- A case-control study.

Edathara PM, Gorre M, Kagita S, Cingeetham A, Annamaneni S, Digumarti R, Satti V. Edathara PM, et al. Among authors: digumarti r. Gene. 2019;721S:100002. doi: 10.1016/j.gene.2018.100002. Epub 2018 Dec 17. Gene. 2019. PMID: 34530993 Free PMC article.

8

Omacetaxine mepesuccinate in patients with advanced chronic myeloid leukemia with resistance or intolerance to tyrosine kinase inhibitors.

Khoury HJ, Cortes J, Baccarani M, Wetzler M, Masszi T, Digumarti R, Craig A, Benichou AC, Akard L. Khoury HJ, et al. Among authors: digumarti r. Leuk Lymphoma. 2015 Jan;56(1):120-7. doi: 10.3109/10428194.2014.889826. Epub 2014 Apr 28. Leuk Lymphoma. 2015. PMID: 24650054 Clinical Trial.

9

Response to imatinib mesylate in childhood chronic myeloid leukemia in chronic phase.

Linga VG, Ganta RR, Kalpathi KI, Gundeti S, Rajappa SJ, Digumarti R, Paul TR, Tandon A. Linga VG, et al. Among authors: digumarti r. South Asian J Cancer. 2014 Oct;3(4):203-5. doi: 10.4103/2278-330X.142961. South Asian J Cancer. 2014. PMID: 25422804 Free PMC article.

10

Fms like tyrosine kinase (FLT3) and nucleophosmin 1 (NPM1) mutations in de novo normal karyotype acute myeloid leukemia (AML).

Dunna NR, Rajappa S, Digumarti R, Vure S, Kagita S, Damineni S, Rao VR, Yadav SK, Ravuri RR, Satti V. Dunna NR, et al. Among authors: digumarti r. Asian Pac J Cancer Prev. 2010;11(6):1811-6. Asian Pac J Cancer Prev. 2010. PMID: 21338238 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

98 results

Search Page